Description
Retatrutide is a 39-amino-acid peptide classified as a triple agonist, meaning it targets the GIP, GLP-1, and glucagon receptors simultaneously. This combined receptor activity makes it a distinctive subject in metabolic research.
In research models it is studied for its effects on metabolic regulation, appetite, and body-composition outcomes. It is supplied as a lyophilized powder requiring frozen storage for stability, in 10mg, 15mg, and 30mg sizes.
This product is intended for research and laboratory use only. It is not for human consumption.
Reviews
There are no reviews yet.